G12C and G12V appear to be induced by chronic exposure to tobacco carcinogens, which also increases tumor mutational burden (TMB) and PD-1/PD-L1 expression, both of which are predictors of good response to immunotherapy (35–39). The gene discussed is CD274; the disease is neoplasm.